Prevention of radiochemotherapy-induced toxicity with amifostine in patients with malignant orbital tumors involving the lacrimal gland: a pilot study

BACKGROUND: To use amifostine concurrently with radiochemotherapy (CT-RT) or radiotherapy (RT) alone in order to prevent dry eye syndrome in patients with malignancies located in the fronto-orbital region. METHODS: Five patients (2 males, 3 females) with diagnosed malignancies (Non-Hodgkin B-cell Ly...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldblum, David, Ghadjar, Pirus, Curschmann, Juergen, Greiner, Richard, Aebersold, Daniel
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2542992/
https://www.ncbi.nlm.nih.gov/pubmed/18761746
http://dx.doi.org/10.1186/1748-717X-3-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2542992/
https://www.ncbi.nlm.nih.gov/pubmed/18761746
http://dx.doi.org/10.1186/1748-717X-3-22

Ejemplares similares